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httpObjectives: To analyse the biological effects of a 1920 nm endovenous laser (EVL) on extra-fascial great
saphenous vein (GSV) in vitro.
Methods: A 10 cm length of a large tributary bypassing a hypoplastic segment of the GSV (sometimes called an
“extra-fascial GSV”) was obtained during routine varicose vein surgery. The length was treated in ﬁve sections
with different LEEDs (0 (control), 20, 40, 60, and 80 J/cm) with a 1920 nm EVL at 4W power, in a novel in vitro
treatment model. The biological effects were assessed by histological staining of the samples for haematoxylin
and eosin (HE) and Martius Scarlet Blue (MSB), and by immunoﬂuorescent detection of p-p53 and VCAM-1.
Results: Histological analysis showed signiﬁcant structural damage at LEEDs above 60 J/cm, especially in the
intima and media, with the treatment at 80 J/cm causing perforation of the vein wall. In addition, there was a
signiﬁcant increase in p-p53 expression in treated tissue at 60 and 80 J/cm.
Conclusions: Using this ex vivo model, the results indicate that in vitro treatment with a 1920 nm EVL, at or above
an LEED of 60 J/cm and 4 W power, causes signiﬁcant vein wall cell death reaching deep into the media by a
combination of direct thermal damage and apoptosis. A wavelength of 1920 nm appears to be effective for the
endovenous ablation of truncal veins.
 2018 The Author(s). Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Over the last two decades varicose vein surgery has pro-
gressed from invasive open surgical techniques to minimally
invasive endovenous surgery performed under duplex ul-
trasound guidance. Radiofrequency ablation (RFA) was the
ﬁrst successful percutaneous endovenous thermal ablation
technique to be administered for truncal venous reﬂux.
More recently, endovenous lasers (EVL) have been used in
EVL ablation (EVLA), targeting haemoglobin and more
recently water as the chromophore for the laser energy.
There have been many clinical studies looking at the
success rates of EVLA relative to open surgery. Research
has negatively favoured the latter, with reports ofesented at The Royal Society of Medicine, Venous Forum, Annual
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high rates of varicose vein recurrence.1 By comparison, the
post-operative pain, scarring, bruising, and overall recovery
time has been reported to be signiﬁcantly lower with RFA
and EVLA.2 However, a recent meta-analysis looking at the
results of treatment of the great saphenous vein (GSV) 5
years after open surgery, EVLA, and ultrasound foam
sclerotherapy, has shown that these advantages of EVLA
over open surgery appear to be early, and outcomes at 5
years appear to be similar.3 Thus, endovenous thermal
ablation has been the recommended treatment for truncal
venous reﬂux by the National Institute of Health and Care
Excellence4 since 2013 and by the European Society for
Vascular Surgery guidelines in 2015.5
Although the exact biological mechanism of thermal in
induced venous occlusion has not yet been demonstrated, it
has been proposed that transmural vein wall cell death is
essential for ﬁbrotic occlusion after treatment. Following
recent ﬁndings regarding sclerotherapy, apoptosis has been
proposed as a cell death mechanism after thermal abla-
tion.6 The objective of this study was to analyse the bio-
logical effects of a 1920 nm EVL on an ex vivo large tributary
bypassing a hypoplastic segment of the GSV, often called an
Figure 1. Histological analysis of a large extra-fascial tributary bypassing a hypoplastic segment of the great saphenous vein (GSV) treated
with varying LEEDs by a 1920 nm endovenous laser. Stained with Martius Scarlet Blue. Connective tissue appears blue and ﬁbrin red.
Pictures taken at 40 magniﬁcation.
8 H.F. Ashpitel et al.“extra-fascial GSV,” treated in vitro, by histology and
immunoﬂuorescence.
MATERIALS AND METHODS
A 10 cm length of a large tributary of the GSV was obtained
from a patient undergoing routine varicose vein surgery.
After extraction, the length was immediately placed in a
Petri dish containing phosphate buffered saline (PBS). The
vein length was split into ﬁve equal sections. A jacket tipped
laser ﬁbre (NeverTouch Direct, AngioDynamics, Albany, NY,
USA), attached to a 1920 nm EVL (AngioDynamics, Albany,
NY, USA) was inserted into the open end of each section,
and passed up the length of vein. One section was un-
treated, to act as a control, and the other four were treated
with the 1920 nm EVL at 4W, with four different pull back
speeds; 5, 10, 15, and 20 s/cm. Thus, the ﬁve sections taken
from the length of vein were treated with ﬁve differentlinear endovenous energy densities (LEEDs): 0, 20, 40, 60,
and 80 J/cm. After treatment, the sections were immedi-
ately halved.
One half was immediately immersed in 10% buffered
formalin and ﬁxed for 24 hours. Following ﬁxation, the tis-
sue samples were placed into an automatic tissue processor
(Shandon Citadel, Thermo Electron Corporation, Runcorn,
UK) and processed routinely. The samples were then
embedded into parafﬁn wax blocks using an embedding
station (Raymond Lamb Blockmaster II, Thermo Fisher Sci-
entiﬁc, Loughborough, UK). A microtome (Reichert 2040
Microtome, Leica Biosystems, Milton Keynes, UK) was then
used to cut 5 mm sections and these were placed onto
Superfrost slides. The slides were stained with haematoxylin
and eosin (H&E) and Martius Scarlet Blue (MSB). The
staining was performed using an Autostainer (Sakura Tissue-
Tek DRS 2000, Sakura, Alphen aan den Rijn, Netherlands), to
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and 200 magniﬁcations using an EVOS microscope (Elec-
tron Microscopy Sciences, Hatﬁeld, PA, USA).
The other half of each vein section was taken, snap frozen
and mounted in optimal cutting temperature (OCT) com-
pound (Sakura). Sections 6 mm thick were then cut from
these samples using a microtome cryostat (Hyrax C 25,
Zeiss, Oberkochen, Germany) and the sections were taken
onto Superfrost Plus slides (Thermo Fisher Scientiﬁc). These
slides were ﬁxed in ice cold methanol/acetone (50:50) for 9
minutes and were washed with PBS three times. The slides
were then incubated, in a dark humid chamber, with 2%
bovine serum albumin (BSA) in PBS for 1 hour at room
temperature. After a subsequent wash with PBS, the slides
were incubated with a polyclonal rabbit anti-VCAM-1 anti-
body (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
1:100 in 0.2% BSA in PBS for 1 hour at room temperature in
a dark humid chamber. After washing with PBS, the slides
were incubated in the same way with a ﬂuorescein iso-
thiocyanate (FITC) labelled anti-rabbit IgG antibody (Santa
Cruz Biotechnology Inc.) 1:250 in 0.2% BSA in PBS.
The same slides were then double stained; using a goat
anti-p-p53 antibody (Santa Cruz Biotechnology Inc.) 1:100 in
0.2% BSA in PBS for 1 hour and a cyanin-3 (Cy3) labelled
anti-goat IgG antibody (Santa Cruz Biotechnology Inc.) 1:250
in 0.2% BSA in PBS. Five minutes prior to the end of the last
incubation, one drop of 4,6-diamidine-2-phenylinole chlo-
ride (DAPI) was added (1 mg/mL in 0.2% BSA in PBS).
After incubation, coverslips were mounted onto the slides
using Mowiol solution (10% Mowiol [SigmaeAldrich, Poole,
UK] in 25% glycerol with 0.1% p-phenylenediamine). Visual-
isation of the ﬂuorescence was undertaken using a ﬂuores-
cence microscope (Olympus BX61, Olympus, Hamburg,
Germany).Quantiﬁcationof these imageswas thenperformed
using software (SimplePCI, Hamamatsu, Shizuoka, Japan) to
measure the intensity of ﬂuorescence in each section.
The study received a favourable ethical opinion from the
NRES Committee South East Coast e Surrey (13/LO/0058)
and the University of Surrey Ethics Committee (EC/2013/
23/FHMS/FS). All human tissue samples were used and
stored in accordance with Human Tissue Act (HTA) 2004 UK
guidelines. Patient consent was collected and patient in-
formation was stored in accordance with the Data Protec-
tion Act (UK, 1998). Generation of graphs and all statistical
analysis were performed using GraphPad Prism 7 (GraphPad
Software Inc., La Jolla, CA, USA).RESULTS
Histological analyses showed no signiﬁcant damage at 0, 20,
and 40 J/cm. Signiﬁcant asymmetrical thermal damage was
observed throughout the intima and media at 60 J/cm and
extensive damage throughout the entirety of the vein wall
at 80 J/cm (Fig. 1). At 80 J/cm perforation of the vein wall
was observed.
Visual analysis of the immunoﬂuorescence showed no
difference in p-p53 or VCAM-1 expression between the
control and vein segments treated at 20 and 40 J/cm.Observation indicated an increase in p-p53 expression in
the endothelium of the vein sample treated at 60 J/cm, but
no difference for VCAM-1. Furthermore, vein sections
treated with an LEED of 80 J/cm showed an upregulation of
p-p53, with no change in VCAM-1 expression (Fig. 2).
Quantitative analysis of p-p53 ﬂuorescence intensity
showed no signiﬁcant difference in expression among the
control, 20, and 40 J/cm (p > .05), conﬁrming the visual
analysis. There was a signiﬁcant increase in the expression
of p-p53, compared with the control, at 60 and at 80 J/cm
(p ¼ .0077 and p ¼ .0465, respectively), both in the
endothelial cell layer alone and across the vein wall.
Quantiﬁcation of VCAM-1 ﬂuorescence showed no signiﬁ-
cant difference in the expression throughout the vein wall
(Fig. 3).DISCUSSION
This is a preliminary study, in one vein from one patient,
which has outlined the biological effects of a 1920 nm EVL
using an ex vivo model of EVLA treatment on the tributary
vein wall. By performing both histological and immunohis-
tochemical analysis on vein samples treated in vitro, this
work has been able to show the extent of heat induced cell
damage caused at different LEEDs, and conﬁrm the pres-
ence of apoptotic cell markers within the vein wall. The
results clearly show that the extent of thermal damage to
the vein wall increases, as the LEED increases, with signiﬁ-
cant structural damage to the vein wall observed with
treatments above 60 J/cm using a power of 4W. This is in
keeping with work done by the present authors in the same
model but with the more commonly used 1470 nm EVLA,
which has been presented internationally and is being
submitted for publication.
p53 is a tumour suppressor gene, which is activated by
pro-apoptotic signals, to p-p53. Observations of the acti-
vation of p53 to p-p53 at 60 and at 80 J/cm, imply a role for
apoptosis in ﬁbrotic occlusion and atrophy after EVLA of the
GSV. Furthermore, by obtaining a large tributary bypassing a
hypoplastic segment of the GSV (the “extra-fascial GSV”),
rather than using superﬁcial tributaries obtained during
phlebectomies, the analysis is more comparable with clin-
ical treatment of an incompetent GSV. Anatomical studies
on the structure of the tributaries that bypass hypoplastic
sections of the GSV have shown that the vein wall is similar
in structure to the truncal GSV above the hypoplastic
segment. However, the vein wall of the tributary is some-
what thinner - 89% of the GSV wall thickness in one study7
and 53% in the mid-thigh in another.8
Possible further limitations of this model include that
being ex vivo, the vein is not surrounded by tissue and so
the adventitial vena vasorum are empty and not ﬂowing,
and there is no blood within the vein lumen during treat-
ment. As regards the former point, a vein treated in vivo is
surrounded by tumescence and so this vein suspended
within tumescence ﬂuid during treatment is not in a dis-
similar environment. The presence of blood within the
lumen is regarded as important in some models,9 but when
Figure 3. Quantiﬁcation of the intensity of p-p53 and VCAM-1 ﬂuorescence in vein sections treated with varying LEEDs by a 1920 nm
endovenous laser. Data expressed as mean  SD. N ¼ 5. Comparisons made by unpaired t test. p < .05. * < .0465, ** < .0077.
Figure 2. Immunohistochemical analysis of large extra-fascial tributary of GSV sections treated with varying LEEDs by a 1920 nm endo-
venous laser. Double stained with p-p53 appearing red, VCAM-1 appearing green, and DAPI staining the nuclei blue. Pictures taken at 100
magniﬁcation.
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tumescence ﬂuid around the vein, there is little if any blood
remaining in the vein at the time of treatment.10
In conclusion, the present ex vivo study shows that
treatment of a large tributary bypassing a hypoplastic
segment of the GSV, in vitro, with a 1920 nm EVL, at or
above a LEED of 60 J/cm at 4 W, leads to signiﬁcant cell
death in the vein wall by a combination of direct thermal
damage and apoptosis, which reaches deep into the media
of the vein wall. Although only one vein was used in this
preliminary study, this ﬁnding suggests that this wavelength
could be used to ablate incompetent truncal veins at LEEDs
similar to those used with the 1470 nm EVL.
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